From:
Integrity Research Institute <[email protected]> ...... a great bioenergetics answer to the recent complex discussion about vaccines and the question of whether they can prevent the initial infection from a coronavirus. Medical researchers at Columbia University have come up with the answer in the form of a nasal spray. Specifically, it is a intranasal fusion inhibitory lipopeptide that prevents direct contact SARS-CoV-2 transmission as reported on bioRiv: DOI: 10.1101/2020.11.04.361154 Similar to colloidal silver spray, it may prevent infection in people exposed to the new coronavirus, since it blocks the usual pathway for the virus to enter the body. “People who cannot be vaccinated or do not develop immunity will particularly benefit from the spray. The antiviral is easily administered and, based on the scientists’ experience with other respiratory viruses, protection would be immediate and last for at least 24 hours. The scientists hope to rapidly advance the preventative approach to human trials with the goal of containing transmission during this pandemic.” Enjoy ...... in SILvation, DH in OZ
